tiprankstipranks
Trending News
More News >
Igc Pharma, Inc. (IGC)
:IGC
US Market
Advertisement

IGC Pharma (IGC) Financial Statements

Compare
925 Followers

IGC Pharma Financial Overview

IGC Pharma's market cap is currently $30.92M. The company's EPS TTM is $-0.02; its P/E ratio is ―; IGC Pharma is scheduled to report earnings on June 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue$ 1.27M$ 1.34M$ 911.00K$ 397.00K$ 898.00K
Gross Profit$ 619.00K$ 733.00K$ 442.00K$ 194.00K$ 113.00K
Operating Income$ -7.45M$ -9.80M$ -11.57M$ -15.43M$ -8.72M
EBITDA$ -6.83M$ -9.16M$ -10.91M$ -14.78M$ -8.25M
Net Income$ -7.12M$ -13.00M$ -11.51M$ -15.02M$ -8.81M
Balance Sheet
Cash & Short-Term Investments$ 405.00K$ 1.20M$ 3.35M$ 10.46M$ 14.63M
Total Assets$ 8.75M$ 9.90M$ 17.18M$ 26.83M$ 35.87M
Total Debt$ 238.00K$ 345.00K$ 481.00K$ 488.00K$ 985.00K
Net Debt$ -167.00K$ -853.00K$ -2.71M$ -9.97M$ -13.56M
Total Liabilities$ 2.42M$ 2.58M$ 2.27M$ 2.94M$ 3.06M
Stockholders' Equity$ 6.33M$ 7.32M$ 14.91M$ 23.89M$ 32.80M
Cash Flow
Free Cash Flow$ -5.28M$ -5.71M$ -7.67M$ -8.20M$ -12.39M
Operating Cash Flow$ -4.79M$ -5.20M$ -7.05M$ -7.46M$ -10.80M
Investing Cash Flow$ -442.00K$ -317.00K$ -235.00K$ -742.00K$ 3.39M
Financing Cash Flow$ 4.45M$ 3.52M$ 100.00K$ 4.14M$ 14.69M
Currency in USD

IGC Pharma Earnings and Revenue History

IGC Pharma Debt to Assets

IGC Pharma Cash Flow

IGC Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis